Bayer shareholders vent ire over Monsanto-linked stock rout

BONN (Reuters) – Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s $63 billion takeover of seed maker Monsanto. Werner Baumann, CEO of German pharmaceutical and chemical maker Bayer AG, attends the annual general shareholders meeting in Bonn, Germany, Continue Reading

U.S. jury hits Bayer with $81 million in Roundup cancer trial

FILE PHOTO: Monsanto’s Roundup weedkiller atomizers are displayed for sale at a garden shop near Brussels, Belgium November 27, 2017. REUTERS/Yves Herman/File Photo (Reuters) – A U.S. jury on Wednesday awarded $80.9 million to a man who claimed his use of Bayer AG’s glyphosate-based weed killer Roundup caused his cancer, Continue Reading